Angelos Koutras Selected Research

CD40 Antigens

1/2021

Genetic Variations of CD40 and LTβR Genes Are Associated With Increased Susceptibility and Clinical Outcome of Non-Small-Cell Carcinoma Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Angelos Koutras Research Topics

Disease

53	Neoplasms (Cancer) 10/2022 - 07/2002
50	Breast Neoplasms (Breast Cancer) 10/2022 - 03/2006
6	Peripheral Nervous System Diseases (PNS Diseases) 01/2007 - 08/2005
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2007
3	Renal Cell Carcinoma (Grawitz Tumor) 05/2021 - 04/2019
3	Neoplasm Metastasis (Metastasis) 05/2019 - 12/2016
3	Adenocarcinoma 05/2019 - 01/2007
3	Carcinoma (Carcinomatosis) 05/2019 - 06/2014
3	Colorectal Neoplasms (Colorectal Cancer) 04/2018 - 01/2011
2	Colonic Neoplasms (Colon Cancer) 04/2020 - 01/2007
2	Disease Progression 01/2018 - 07/2004
2	Anemia 02/2016 - 06/2003
2	Thrombosis (Thrombus) 02/2016 - 06/2010
1	Kidney Neoplasms (Kidney Cancer) 05/2021
1	Head and Neck Neoplasms (Head and Neck Cancer) 03/2021
1	Adenoma (Adenomas) 04/2018
1	Adenocarcinoma of Lung 12/2016
1	Fatigue 02/2016
1	Chromosomal Instability (Chromosome Stability) 01/2016
1	Hypoxia (Hypoxemia) 09/2015
1	Neutropenia 07/2015

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 10/2022 - 01/2012
15	Messenger RNA (mRNA)IBA 01/2022 - 01/2012
15	ParaffinIBA 01/2020 - 01/2012
14	Trastuzumab (Herceptin)FDA Link 10/2022 - 03/2013
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2011
12	Formaldehyde (Formol)FDA Link 01/2020 - 01/2012
11	AnthracyclinesIBA 01/2022 - 01/2012
11	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 08/2005
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2021 - 01/2011
6	human ERBB2 proteinIBA 10/2022 - 01/2019
6	Phenobarbital (Luminal)FDA Link 01/2017 - 01/2014
6	Hormones (Hormone)IBA 01/2016 - 01/2012
5	ErbB Receptors (EGF Receptor)IBA 01/2022 - 05/2011
5	taxaneIBA 01/2020 - 01/2007
5	Docetaxel (Taxotere)FDA Link 09/2015 - 01/2007
5	Cisplatin (Platino)FDA LinkGeneric 01/2007 - 08/2005
4	Taxoids (Taxanes)IBA 01/2022 - 07/2014
4	Bevacizumab (Avastin)FDA Link 04/2019 - 09/2011
3	Epirubicin (Ellence)FDA LinkGeneric 01/2020 - 01/2012
3	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 05/2019 - 01/2015
3	Cyclin D1IBA 01/2019 - 01/2017
2	LigandsIBA 01/2022 - 01/2018
2	thiamine triphosphorate (TTP)IBA 01/2022 - 01/2018
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2021 - 12/2016
2	Protein Isoforms (Isoforms)IBA 04/2021 - 10/2014
2	Immune Checkpoint InhibitorsIBA 06/2020 - 05/2020
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2020 - 01/2007
2	Fluorouracil (Carac)FDA LinkGeneric 04/2020 - 01/2020
2	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 02/2011
2	Estrogen ReceptorsIBA 08/2019 - 01/2012
2	TOR Serine-Threonine KinasesIBA 04/2019 - 01/2016
2	CyclinsIBA 01/2019 - 01/2017
2	Somatomedin Receptors (Somatomedin Receptor)IBA 11/2018 - 01/2014
2	Vascular Endothelial Growth Factor CIBA 01/2018 - 09/2015
2	OsteopontinIBA 01/2017 - 09/2015
2	DNA (Deoxyribonucleic Acid)IBA 05/2016 - 01/2013
2	Androgen Receptors (Androgen Receptor)IBA 01/2015 - 06/2014
2	Phosphotransferases (Kinase)IBA 01/2015 - 05/2011
2	ixabepilone (BMS 247550)FDA Link 10/2014 - 01/2013
2	Pharmaceutical PreparationsIBA 06/2010 - 07/2004
2	Carboplatin (JM8)FDA LinkGeneric 01/2007 - 12/2005
2	PlatinumIBA 01/2007 - 01/2006
2	Vitamin E FDA LinkGeneric 11/2006 - 09/2006
1	Coloring Agents (Dyes)IBA 01/2022
1	LipofuscinIBA 01/2022
1	Gefitinib (Iressa)FDA Link 10/2021
1	Tyrosine Kinase InhibitorsIBA 10/2021
1	CD40 AntigensIBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	B-Cell Activation Factor ReceptorIBA 01/2021
1	Lymphotoxin beta ReceptorIBA 01/2021
1	NivolumabIBA 01/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020
1	CytokinesIBA 01/2020
1	ChemokinesIBA 01/2020
1	cabazitaxel FDA Link 01/2020
1	Actins (F Actin)IBA 08/2019
1	Tamoxifen FDA LinkGeneric 08/2019
1	temsirolimus FDA Link 04/2019
1	Insulin-Like Growth Factor I (IGF-1)IBA 11/2018
1	Monoclonal AntibodiesIBA 11/2018
1	Cell-Free Nucleic AcidsIBA 04/2018
1	HematinicsIBA 02/2016
1	Hemoglobins (Hemoglobin)IBA 02/2016
1	IronIBA 02/2016
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2016
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 09/2015
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 09/2015
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 09/2015

Therapy/Procedure

27	Drug Therapy (Chemotherapy) 01/2022 - 07/2002
17	Adjuvant Chemotherapy 01/2019 - 01/2012
5	Therapeutics 01/2022 - 01/2007
2	Semiconductors 05/2016 - 01/2016
1	Particle Accelerators 05/2021
1	Radiotherapy 05/2021
1	Immunotherapy 05/2020
1	Precision Medicine 01/2020
1	Aftercare (After-Treatment) 08/2019
1	Drug Tapering 07/2015